Stemsation International Inc (STSN) fair value: what the stock is really worth
As of Sep 28, 2026: fair value of Stemsation International Inc $0.02, price $0.02, upside -8.1%, quality 39 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Stemsation International Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range $0.0024 – $0.0685 · fair‑value band $0.0160 – $0.0177 · the $0.0174 price screens above the $0.0160 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Stemsation International in your weekly email
Every Wednesday you see whether Stemsation International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. The company sells its products through business to business and direct to consumers channels. Stemsation International, Inc. was incorporated in 2006 and is headquartered in Plantation, Florida.
Stock analysis
Stemsation International Inc (STSN) currently trades at $0.0174, while our model-based Fair Value estimate is $0.0160, so the stock looks roughly fairly valued today (gap 8.8%).
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 88/100, which puts the evidence level at low.
Scenario range: $0.0160 (bear) to $0.0177 (bull), the price of $0.0174 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Stemsation International Inc reported revenue of $217K in FY2020 versus $3.4K in FY2010, a compound +51.6%/yr. Reported net income was −$464K in FY2025.
Key figures
Market cap $8.1M · Return on assets (EBIT) −99.1% · Free cash flow −$356K · Net debt $1.5M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 27 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 625% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −19% fair-value upside, at −8%, STSN screens cheaper than that median.
Fair Value models
Bear $0.0160Fair Value $0.0160Bull $0.0177
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+6,608.1%
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+51.6%
’10
’19
’20
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare Stemsation International Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 585 stocks
Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score40 · Bottom 25%
Fair Value upside−8.0% · Above median
Profitability
Return on assets0.0% · Below median
Operating margin (TTM)0.0% · Below median
Growth and dividend
Revenue growth0.0% · Below median
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Stemsation International Inc Fair Value". https://www.fairvalue-calculator.com/stock/STSN
Frequently asked questions
Is Stemsation International Inc (STSN) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0160 versus a price of $0.0174, about −8% upside (fairly valued).
What is the fair value of STSN?
Our model-based fair value for Stemsation International Inc is $0.0160 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0174.
What is the quality score of STSN?
Stemsation International Inc has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Stemsation International Inc (STSN)?
Our model-based price target is the fair value of $0.0160 (as of Sep 27, 2026) from 1 valuation models. Cautious scenario $0.0160, optimistic scenario $0.0177. It is a calculation from audited fundamentals, not an analyst target.
What is the Stemsation International Inc stock forecast for 2026?
Our models put fair value at $0.0160, about −8% upside versus a price of $0.0174 (fairly valued). Cautious scenario $0.0160, optimistic scenario $0.0177. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Stemsation International Inc (STSN)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Stemsation International Inc it is $0.0160 per share (as of Sep 27, 2026), against a price of $0.0174. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Stemsation International Inc stock overvalued or undervalued in 2026?
As of Sep 27, 2026, STSN trades above its calculated fair value: price $0.0174, fair value $0.0160, a gap of about −8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of STSN?
No. The price is what the market pays today ($0.0174); the fair value is what the company's own numbers justify ($0.0160). For Stemsation International Inc the two are $0.0014 per share apart. That gap is exactly why we show both numbers side by side.
How much is Stemsation International Inc worth?
The market values Stemsation International Inc at about $8.1M (market capitalisation, as of Sep 27, 2026). Per share that is $0.0174; our models calculate a fair value of $0.0160 per share.
What do the bullish and bearish scenarios say about STSN?
Our models span a range for Stemsation International Inc: cautious scenario $0.0160, base $0.0160, optimistic $0.0177 per share (as of Sep 27, 2026, price $0.0174). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is STSN from its 52-week high?
Stemsation International Inc trades at $0.0174, about 15% below its 52-week high of $0.0205 and 625% above the low of $0.0024 (as of Sep 28, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0160 is for.
Which stocks are comparable to Stemsation International Inc?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Stemsation International Inc stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0174, calculated fair value $0.0160 (−8%), Quality Score 39/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of STSN calculated?
We run Stemsation International Inc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0160, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Stemsation International Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Stemsation International Inc (STSN)?
The closing price on Sep 28, 2026 was $0.0174. Our model-based fair value is $0.0160, about −8% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Stemsation International Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0160 to $0.0177), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Stemsation International Inc
How large is the market capitalisation of Stemsation International Inc (STSN)?
The market capitalisation of Stemsation International Inc is $8.1M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the EBIT return on assets of Stemsation International Inc (STSN)?
On an EBIT basis the return on assets of Stemsation International Inc is −99.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does Stemsation International Inc (STSN) generate?
The free cash flow of Stemsation International Inc is −$356K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Stemsation International Inc (STSN) carry?
The net debt of Stemsation International Inc is $1.5M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Stemsation International Inc in the live analysis
One click puts Stemsation International Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026